The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated phase I study results of PHE885, a T-Charge manufactured BCMA-directed CAR-T cell therapy, for patients (pts) with r/r multiple myeloma (RRMM).
 
Adam Samuel Sperling
Consulting or Advisory Role - Novartis; Roche/Genentech
 
Benjamin Avi Derman
Honoraria - OncLive/MJH Life Sciences; Plexus
Consulting or Advisory Role - Cota Healthcare; Janssen Scientific Affairs; Sanofi/Aventis
Other Relationship - Bristol-Myers Squibb/Celgene
 
Sarah Nikiforow
Consulting or Advisory Role - GlaxoSmithKline; Iovance Biotherapeutics; Kite/Gilead
 
Soo-Yeon Im
No Relationships to Disclose
 
Shuntaro Ikegawa
Other Relationship - Taisho Pharmaceutical Holdings
 
Rao H. Prabhala
No Relationships to Disclose
 
Diego Hernandez Rodriguez
No Relationships to Disclose
 
Yifang Li
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
David S. Quinn
Employment - Novartis
 
David Pearson
Employment - Novartis
 
Dexiu Bu
Employment - Novartis
Patents, Royalties, Other Intellectual Property - Novartis
 
Jennifer Mataraza
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jessica Liegel
Research Funding - Janssen
 
Anita D'Souza
Consulting or Advisory Role - Akcea Therapeutics; Bristol-Myers Squibb/Celgene; Janssen Oncology; Pfizer; Prothena
Research Funding - Abbvie (Inst); Caelum Biosciences (Inst); Janssen Oncology (Inst); Prothena (Inst); Regeneron (Inst); Sanofi (Inst); Sorrento Therapeutics (Inst); Takeda (Inst); TeneoBio (Inst)
Travel, Accommodations, Expenses - Imbrium Therapeutics
 
Lawrence Rispoli
Stock and Other Ownership Interests - Novartis
 
Marc Credi
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Jerome Ritz
Stock and Other Ownership Interests - Clade Therapeutics; Garuda Therapeutics; LifeVault Bio/GoodCell; Tscan Therapeutics
Consulting or Advisory Role - Akron Biotech; Akron Biotech; Avrobio; Clade Therapeutics; Draper Laboratory; Garuda Therapeutics; LifeVault Bio/GoodCell; Novartis Institutes for BioMedical Research; Smart Immune; Talaris; TScan Therapeutics
Research Funding - Amgen; Equillium; Kite/Gilead; Novartis Institutes for BioMedical Research; Oncternal Therapeutics, Inc (Inst)
 
Andrzej J. Jakubowiak
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi
 
Serena De Vita
Employment - Novartis
 
Nikhil C. Munshi
Stock and Other Ownership Interests - C4 Therapeutics; OncoPep; Raqia
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; BeiGene; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Janssen; Karyopharm Therapeutics; Legend Biotech; Novartis; OncoPep; Raqia; Sebia; Takeda
Patents, Royalties, Other Intellectual Property - Oncopep